World's Best Scientists 2026 revealed!
Aleš Linhart

Aleš Linhart

D-Index & Metrics

Medicine

D-Index
72
Citations
68101
World Ranking
19739
National Ranking
13

Overview

Aleš Linhart is affiliated with Charles University in the Czech Republic and has a significant body of work in the field of medicine, focusing primarily on cardiology and cardiovascular medicine.

Their recent notable publications include:

  • 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, 2021, European Heart Journal
  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice, 2021, European Heart Journal
  • 2023 ESC Guidelines for the management of acute coronary syndromes, 2023, European Heart Journal
  • 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, 2022, European Heart Journal
  • 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, 2022, European Heart Journal

The scientist frequently collaborates with several co-authors, including Gabriela Dostálová, Derralynn Hughes, Jan Bělohlávek, Miloš Táborský, and Štěpán Havránek, reflecting a collaborative research approach.

Aleš Linhart's work appears regularly in journals such as:

  • Cor et Vasa
  • Molecular Genetics and Metabolism
  • European Heart Journal
  • ESC Heart Failure
  • European Heart Journal - Cardiovascular Imaging

Their research spans several subfields within medicine, particularly:

  • Cardiology and Cardiovascular Medicine
  • Physiology
  • Surgery
  • Molecular Biology
  • Pulmonary and Respiratory Medicine

Main topics of their research encompass:

  • Lysosomal Storage Disorders Research
  • Carbohydrate Chemistry and Synthesis
  • Trypanosoma species research and implications
  • Cardiomyopathy and Myosin Studies
  • Cardiovascular Function and Risk Factors
  • Heart Failure Treatment and Management
  • Pulmonary Hypertension Research and Treatments

Best Publications

  • 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

    Giuseppe Mancia;Robert Fagard;Krzysztof Narkiewicz;Josep Redon

  • 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

    Gilles Montalescot;Udo Sechtem;Stephan Achenbach;Felicita Andreotti

  • 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy : The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)

    Michele Brignole;Angelo Auricchio;Gonzalo Baron-Esquivias;Pierre Bordachar

  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

    Frank L J Visseren;François Mach;Yvo M Smulders;David Carballo

  • 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

    Stephan Windecker;Philippe Kolh;Fernando Alfonso;Jean-Philippe Collet

  • Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

    Alida L. P. Caforio;Sabine Pankuweit;Eloisa Arbustini;Cristina Basso

  • Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

    Matthew T. Roe;Paul W. Armstrong;Keith A.A. Fox;Harvey D. White

  • Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice : a position statement of the ESC working group on myocardial and pericardial diseases

    Yigal M Pinto;Perry M Elliott;Eloisa Arbustini;Yehuda Adler

  • Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

    A. Mehta;R. Ricci;U. Widmer;F. Dehout

  • Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

    Pablo Garcia-Pavia;Claudio Rapezzi;Yehuda Adler;Michael Arad

  • Darapladib for preventing ischemic events in stable coronary heart disease.

    Harvey D. White;Claes Held;Ralph Stewart;Elizabeth Tarka

  • Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study

    G Habib;P A Erba;P A Erba;B Iung;E Donal

  • Fabry disease revisited: Management and treatment recommendations for adult patients

    Alberto Ortiz;Dominique P. Germain;Robert J. Desnick;Juan Politei

  • Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.

    Ales Linhart;Christoph Kampmann;José L Zamorano;Gere Sunder-Plassmann

  • Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases

    Claudio Rapezzi;Eloisa Arbustini;Alida L P Caforio;Philippe Charron

  • Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism.

    Jan Bĕlohlávek;Vladimír Dytrych;Aleš Linhart

  • Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey

    A Mehta;J T R Clarke;R Giugliani;P Elliott

  • Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data

    A. Mehta;M. Beck;P. Elliott;R. Giugliani

  • New insights in cardiac structural changes in patients with Fabry's disease.

    Aleš Linhart;Tomáš Paleček;Jan Bultas;James J. Ferguson

  • Chronic thromboembolic pulmonary hypertension

    Michael Aschermann;Pavel Jansa;David Ambrož;Pavel Poláček

Frequent Co-Authors

Perry M. Elliott
Perry M. Elliott University College London
Renata Cifkova
Renata Cifkova Charles University
Derralynn Hughes
Derralynn Hughes Royal Free London NHS Foundation Trust
Petr Widimsky
Petr Widimsky Charles University
Atul Mehta
Atul Mehta The Royal Free Hospital
Milan Sonka
Milan Sonka University of Iowa
José Luis Zamorano
José Luis Zamorano Hospital Ramon y Cajal
Massimo F. Piepoli
Massimo F. Piepoli Sant'Anna School of Advanced Studies
Christoph Wanner
Christoph Wanner University of Würzburg
Patrizio Lancellotti
Patrizio Lancellotti University of Liège

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring alternatives or complementary paths to studying Medicine in the USA, there are many online degrees and career options to consider. Nursing is a popular choice, and prospective students often ask, "whats the easiest nursing program to get into?" Some schools offer streamlined admissions without demanding prerequisites or entrance exams.

For those eager to start working sooner, medical billing and coding schools with financial aid are an accessible way into the healthcare field, blending clinical knowledge with administrative skills. Similarly, students who worry about standardized testing can look into nursing schools that don't require teas or hesi for admission, making the application process more straightforward.

Those interested in leadership or administrative roles may benefit from a healthcare administration associate degree online, which prepares graduates for entry-level management in healthcare settings. Exploring these options can open doors to rewarding healthcare careers even beyond the traditional path of a medical degree.

Best Scientists Citing Aleš Linhart

Trending Scientists